Amanote Research
Register
Sign In
395. Tumor Recurrences Share Immunogenic Antigens Across Both Tumor Types and Primary Treatments Which Can Be Therapeutically Targeted With VSV-cDNA Libraries
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34730-x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
Hypoxia Increases Heparanase-Dependent Tumor Cell Invasion, Which Can Be Inhibited by Antiheparanase Antibodies
Cancer Research
Cancer Research
Oncology
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis
Cancer Research
Cancer Research
Oncology
Energy Status Parameters, Hypoxia Fraction and Radiocurability Across Tumor Types
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Comprehensive Transcriptomic Analysis of Cell Lines as Models of Primary Tumors Across 22 Tumor Types
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Sestrin1, a Tumor Suppressor That Can Be Rescued
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Tumor-Targeted Drug Delivery With Aptamers
Current Medicinal Chemistry
Organic Chemistry
Biochemistry
Drug Discovery
Molecular Medicine
Pharmacology
Tumor Fistulization Associated With Targeted Therapy
Journal of Computer Assisted Tomography
Nuclear Medicine
Radiology
Imaging
Human Tumor Antigens and Cancer Immunotherapy
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Nano-Pulse Stimulation Is a Physical Modality That Can Trigger Immunogenic Tumor Cell Death
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
